Abstract
Anlotinib is a new type of small-molecule multi-target tyrosine kinase inhibitor with inhibitory effects against angiogenesis and tumor growth. An eff......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
